// App-Quantinova.ai

: Sickle Cell Disease and Venous Thromboembolism: Hospital Mortality, Length of Stay and Cost

Researchers

Presenter

  • Michael Rainone

Principal Investigators

  • Stuthi Pavani Perimbeti

  • Rishi Shrivastav

  • Jeffrey A. Glassberg

  • Lawrence Cytryn

Medical Centers

  • Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West Hospitals, Icahn School of Medicine, New York, NY

  • Mount Sinai St. Luke's and Mount Sinai West Hospital, New York, NY

  • Division of Hematology and Oncology, Department of Medicine and Department of Emergency Medicine, Mount Sinai Medical Center, New York, NY

  • Division of Hematology and Oncology, Mount Sinai St. Luke's and Mount Sinai West hospitals, Icahn School of Medicine, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Sickle cell anemia

  • Pulmonary embolism

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A